Crossmark

Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics

Crossref DOI link: https://doi.org/10.1016/j.anpede.2014.02.005

Published Print: 2015-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Navas-López, V.M.

Blasco-Alonso, J.

Lacasa Maseri, S.

Girón Fernández-Crehuet, F.

Serrano Nieto, M.J.

Vicioso Recio, M.I.

Sierra Salinas, C.
License Information

Text and Data Mining valid from 2015-07-01
More Information

This article is maintained by: Elsevier

Article Title: Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics

Journal Title: Anales de Pediatría (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.anpede.2014.02.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.anpedi.2014.02.027

Content Type: article

Copyright: Copyright © 2013 Asociación Española de Pediatría. Published by Elsevier España S.L. All rights reserved.